Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Takashi Shoda, President and Representative Director
(Code no.: 4568, First Section, Tokyo, Osaka and Nagoya Stock Exchanges)
Please address inquiries to Toshiaki Sai, General Manager,
Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com/
Daiichi Sankyo's Research Foundation Establishes
Second Annual Clinical Pharmacology Research Award
Tokyo, Japan (July 13, 2009) - Daiichi Sankyo Company, Limited (TSE:4568) announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology (headquarters: Tokyo, Director General: Kiyoshi Morita) has established "Japan Research Foundation for Clinical Pharmacology Research Award" to recognize excellence in regards to research results in the field of clinical pharmacology last year and five young researchers were nominated for the second award this year.
Awardees are selected from research papers submitted from projects funded with subsidies from the foundation. Innovative research projects with expectations for future development are eligible for the award.
The Foundation hopes that the award will motivate young researchers in clinical pharmacology involved in establishment of appropriate drug treatments to encourage future research results. The conferment ceremony and presentations of the research themes will be held on November 5, 2009.
The mission of the Foundation is to promote clinical pharmacology and to foster clinical pharmacologists. The Foundation was established in 1975 and in its 34-year history it has worked on a variety of projects relating to clinical pharmacology including promotion of research, overseas studies for Japanese researchers and Asian international collaboration.
Awardees / Organization / Research theme
Taka-aki Koshimizu
Department of Genomic Drug Discover Science Graduate School of Pharmaceutical Science Kyoto University Faculty of Pharmaceutical Science, Kyoto University
(Present) Division of Molecular Pharmacology, Department of Pharmacology, Jichi Medical University
Analysis of gene expression profiles and transcription factor binding sites for tailored cancer therapy
Hiroshi Suzuki
Department of Pharmacy School of Medicine, The University of Tokyo
Development of systematic prediction method for pharmacokinetic drug-drug interaction
Sachiko Takenoshita(Nakaya)
Department of Pharmacology, ST. Marianna University School of Medicine
Cytochrome P450 mRNA expression profile in small intestine and it's relationship to genetic polymorphisms in Japanese subjects
Tetsuya Nakatsura
Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East
Phase I clinical study of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
Kenichi Nomura
Department of Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science
(Present) Department of Hematology/Oncology, Iwate Medical University
Establishment of optimized dosage and frequency of cefozopran for febrile neutropenia patients based on population pharmacokinetic and pharmacodynamic analysis
